Comments
Shares of Ranbaxy Laboratories jumped by over 5 per cent in morning trade on the bourses today after the company posted a better-than-expected profit of Rs 304.4 crore for the first quarter ended March 31, 2011.
The scrip of the country’s biggest drug-maker rose by 5.37 per cent to touch an early high of Rs 473.25 on BSE.
In a similar fashion, the stock zoomed up by 5 per cent to touch a high of Rs 472.90 on the National Stock Exchange.
On the volume front, over 26 lakh shares were traded on the two bourses within the first few minutes of trade.
“The results have matched the streets expectations, which are definitely better than expected, that is why the stock is seeing buying interest by the investors,” Ashika Stock Brokers Research Head, Mr Paras Bothra said.
The drug major yesterday posted a consolidated profit after tax (PAT) of Rs 304.4 crore for the first quarter ended March 31, 2011.
The company’s PAT for the quarter is significantly lower than the Rs 960.6 crore that it had posted in the same period the previous year.
However, the figures were not comparable as it had witnessed a significant jump in sales in the same period last year through the launch of antiviral, Valacyclovir with 180 days of exclusive marketing rights in the US in the last quarter of 2009.
The results were announced after market close yesterday.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.